Lamivudine and Zidovudine (Lake Erie Medical DBA Quality Care Products LLC)
Welcome to the PulseAid listing for the Lamivudine and Zidovudine drug offered from Lake Erie Medical DBA Quality Care Products LLC. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lake Erie Medical DBA Quality Care Products LLC |
| NON-PROPRIETARY NAME: | Lamivudine and Zidovudine |
| SUBSTANCE NAME: | LAMIVUDINE; ZIDOVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-05-15 |
| END MARKETING DATE: | 0000-00-00 |
Lamivudine and Zidovudine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lamivudine and Zidovudine from Lake Erie Medical DBA Quality Care Products LLC |
| LABELER NAME: | Lake Erie Medical DBA Quality Care Products LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150; 300(mg/1; mg/1) |
| START MARKETING DATE: | 2012-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55700-096_a4f4fad5-6dfe-41ef-b426-b6c96d3d8c3f |
| PRODUCT NDC: | 55700-096 |
| APPLICATION NUMBER: | ANDA202418 |
Other LAMIVUDINE; ZIDOVUDINE Pharmaceutical Manufacturers / Labelers:
